Hillsborough, CA, United States of America

Cameron K Kerrigan


Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Burlingame, CA (US) (2012 - 2017)
  • Hillsborough, CA (US) (2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Cameron K Kerrigan

Introduction

Cameron K Kerrigan is a notable inventor based in Hillsborough, CA (US). He has made significant contributions to the field of medical devices, particularly in drug delivery systems. With a total of 8 patents, Kerrigan's work has advanced the technology used in cardiovascular treatments.

Latest Patents

Kerrigan's latest patents include a drug delivery scaffold or stent with a novolimus and lactide-based coating. This innovative design ensures that novolimus has a minimum amount of bonding to the coating, enhancing the effectiveness of drug delivery medical devices. Another significant patent is a method for electrostatic coating of medical devices, such as stents and balloons. This method involves applying a composition to a polymeric component of a medical device that has little or no conductivity. The process allows for the electrostatic deposition of charged particles, including drugs and biobeneficial agents, onto the medical device, which can also impart imaging capabilities.

Career Highlights

Kerrigan is currently employed at Abbott Cardiovascular Systems, Inc., where he continues to develop innovative medical technologies. His work has been instrumental in improving the safety and efficacy of cardiovascular treatments.

Collaborations

Some of his notable coworkers include Stephen D Pacetti and Ni Ding, who have collaborated with him on various projects within the company.

Conclusion

Cameron K Kerrigan's contributions to the field of medical devices through his patents and innovations have made a significant impact on drug delivery systems. His work continues to shape the future of cardiovascular treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…